Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global Patient-Controlled Analgesia Pumps Market Poised to Surpass US$ 500 Mn by 2026

Press release Description

Albany, New York, May 21, 2018: A new research study titled “Patient-Controlled Analgesia Pumps Market: Global Industry Analysis (2012 – 2016) and Opportunity Assessment (2017 – 2026)” has been added to the comprehensive repository of Market Research Reports Search Engine (MRRSE). According to the study, the global patient controlled analgesia pumps market is likely to reach a valuation of nearly US$ 500 Mn by the end of the forecast period.

The research study offers in-depth analysis and insights on the patient-controlled analgesia pumps market. According to the report, there are a number of macroeconomic and microeconomic factors that are likely to promote the growth of patient-controlled analgesia pumps market. Increasing preference among patients to opt for homecare instead of receiving care in hospitals and clinics has been a key driver for growth.

Although the outlook on the patient controlled analgesia pumps market remains positive, challenges associated with overdosing and lack of patient skills continue to be the key factors that are restraining adoption. Further, challenges associated with gaining necessary regulatory approvals, combined with frequent product recalls have dented the confidence of key players in the market.

In addition to offering in-depth insights and analysis, the research study also offers segment-wise analysis on the basis of product type, region, end user, and application. According to the report, PCA pumps are witnessing higher adoption among end-users, and the trend is likely to continue during the assessment period. The report estimates PCA pumps are likely to witness steady growth over the period of forecast.

By region, the report opines that adoption of patient controlled analgesia pumps will continue to gain ground at a steady pace in Asia Pacific excluding Japan (APEJ). The APEJ region is likely to grow at a steady pace during the assessment period. In addition to APEJ, North America continues to be a leading market for patient controlled analgesia pumps. The North America patient controlled analgesia pumps market is likely to remain concentrated in the US, with Canada accounting for a miniscule revenue share of the market.

The business intelligence study also profiles the business and product strategies of some of the leading players in the patient controlled analgesia pumps market. According to the research study, some of the leading companies in the patient controlled analgesia pumps market include Baxter International, B.Braun Melsungen AG, Becton Dickinson and Company, Ace Medical Co. Ltd., Micrel Medical Devices, Terumo Corporation, Fresenius Kabi Group, Hospira (Pfizer Inc.), and Smiths Group plc.

Browse Full Global  Patient-Controlled Analgesia Pumps Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559